Literature DB >> 29934367

MAPping the kinase landscape of macrophage activation.

Khrystyna Platko1, Paul Lebeau1, Richard C Austin2,3.   

Abstract

ARL11 is a tumor suppressor gene with established pro-apoptotic properties, but its function beyond this role is poorly understood. A new analysis of macrophage activation has identified ARL11 as a novel regulator of a mitogen-activated protein kinase (MAPK). These findings expand on the function of ARL11 beyond its tumor suppressor activity and highlight a novel role as a regulator of macrophage activation and inflammatory response.
© 2018 Platko et al.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29934367      PMCID: PMC6016476          DOI: 10.1074/jbc.H118.003380

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages.

Authors:  S L Weinstein; J S Sanghera; K Lemke; A L DeFranco; S L Pelech
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Familial cancer associated with a polymorphism in ARLTS1.

Authors:  George Adrian Calin; Francesco Trapasso; Masayoshi Shimizu; Calin Dan Dumitru; Sai Yendamuri; Andrew K Godwin; Manuela Ferracin; Guido Bernardi; Devjani Chatterjee; Gustavo Baldassarre; Shashi Rattan; Hansjuerg Alder; Hideaki Mabuchi; Takeshi Shiraishi; Lise Lotte Hansen; Jens Overgaard; Vlad Herlea; Francesca Romana Mauro; Guillaume Dighiero; Benjamin Movsas; Laura Rassenti; Thomas Kipps; Raffaele Baffa; Alfredo Fusco; Masaki Mori; Giandomenico Russo; Chang-Gong Liu; Donna Neuberg; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

3.  ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.

Authors:  Sanna Siltanen; Kirsi Syrjäkoski; Rainer Fagerholm; Tarja Ikonen; Peter Lipman; Jacob Mallott; Kaija Holli; Teuvo L J Tammela; Heikki J Järvinen; Jukka-Pekka Mecklin; Kristiina Aittomäki; Carl Blomqvist; Joan E Bailey-Wilson; Heli Nevanlinna; Lauri A Aaltonen; Johanna Schleutker; Pia Vahteristo
Journal:  Eur J Hum Genet       Date:  2008-03-12       Impact factor: 4.246

Review 4.  ARLTS1 - a novel tumor suppressor gene.

Authors:  Sai Yendamuri; Francesco Trapasso; George A Calin
Journal:  Cancer Lett       Date:  2008-03-28       Impact factor: 8.679

5.  Tumor suppressor functions of ARLTS1 in lung cancers.

Authors:  Sai Yendamuri; Francesco Trapasso; Manuela Ferracin; Rossano Cesari; Cinzia Sevignani; Masayoshi Shimizu; Shashi Rattan; Tamotsu Kuroki; Kristoffel R Dumon; Florencia Bullrich; Chang-gong Liu; Massimo Negrini; Noel N Williams; Larry R Kaiser; Carlo M Croce; George A Calin
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

Review 6.  Mitogen-Activated Protein Kinases and Mitogen Kinase Phosphatase 1: A Critical Interplay in Macrophage Biology.

Authors:  Jorge Lloberas; Lorena Valverde-Estrella; Juan Tur; Tania Vico; Antonio Celada
Journal:  Front Mol Biosci       Date:  2016-06-28

7.  ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling.

Authors:  Subhash B Arya; Gaurav Kumar; Harmeet Kaur; Amandeep Kaur; Amit Tuli
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

  7 in total
  2 in total

1.  Method for Studying the Effect of Gene Silencing on Bacterial Infection-induced ERK1/2 Signaling in Bone-marrow Derived Macrophages.

Authors:  Gaurav Kumar; Subhash B Arya; Amit Tuli
Journal:  Bio Protoc       Date:  2018-12-20

2.  Sarcoid-Like Granulomatous Disease: Pathologic Case Series in World Trade Center Dust Exposed Rescue and Recovery Workers.

Authors:  Vasanthi R Sunil; Jared Radbel; Sabiha Hussain; Kinal N Vayas; Jessica Cervelli; Malik Deen; Howard Kipen; Iris Udasin; Robert Laumbach; Jag Sunderram; Jeffrey D Laskin; Debra L Laskin
Journal:  Int J Environ Res Public Health       Date:  2019-03-06       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.